Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Primary Biliary Cirrhosis
Conditions
Primary Biliary Cirrhosis
Trial Timeline
Aug 1, 2007 → Aug 1, 2010
NCT ID
NCT00575042About Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)
Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle) is a phase 2 stage product being developed by Shionogi for Primary Biliary Cirrhosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00575042. Target conditions include Primary Biliary Cirrhosis.
What happened to similar drugs?
20 of 20 similar drugs in Primary Biliary Cirrhosis were approved
Approved (20) Terminated (6) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00575042 | Phase 2 | Completed |
Competing Products
20 competing products in Primary Biliary Cirrhosis